2seventy bio Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Progress

Author's Avatar
Mar 16, 2023

2seventy+bio%2C+Inc. (Nasdaq: TSVT), a leading immuno-oncology cell therapy company, today reported financial results and recent highlights for the fourth quarter and full year ended December 31, 2022.